← Open Payments lookup

CALVIN LEE: Open Payments

NPI 1003117136 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,631 in 50 payments from 11 companies in 2025. Trend: 2023 $609 · 2024 $819 · 2025 $1,631

Food & beverage: $1,631
CompanyPaymentsAmount
Madrigal Pharmaceuticals15$676
Gilead Sciences, Inc.9$334
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$243
Ipsen Biopharmaceuticals, Inc5$163
Mallinckrodt Hospital Products Inc.2$52
Intra-Sana Laboratories2$43
Invivyd Inc1$33
ABBVIE INC.1$32
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
Mirum Pharmaceuticals, Inc.1$18

Products named: REZDIFFRA, XIFAXAN, IQIRVO, Livdelzi, TERLIVAZ, PEMGARDA, MAVYRET, JARDIANCE.

Industry payments across NY — which companies pay providers there.